Albert Tuyishime
Biographic Data
| ID | 9799090 |
|---|---|
| NAME | Albert Tuyishime |
| GIVEN NAMES | Albert |
| FAMILY NAME | Tuyishime |
| SIGNATURE | TUYISHIME A |
| AFFILIATIONS | Rwanda Biomedical Center |
| ORCID | 0009-0004-3118-4989 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Institutionalizing medical certification of cause of death training
Three decades of community health workers in primary healthcare delivery in Rwanda
BACKGROUND: Community health workers (CHWs) have been instrumental in the delivery of primary healthcare (PHC) services in Rwanda since 1995, with their responsibilities expanding from basic health promotion to integrated community case management. This study explored the evolution, contributions, challenges and policy implications of Rwanda CHW programme over the past three decades. METHODS: A qualitative descriptive study was conducted across 1…
Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda
Malaria treatment failures associated with reduced efficacy of chloroquine (CQ) and amodiaquine (AQ) antimalarial drugs emerged in Rwanda during the 1980s, prompting the policy shift towards adopting artemisinin-based combination therapies in 2006 as an alternative. However, recent findings from malaria surveillance and therapeutic efficacy studies have revealed a countrywide increase in antimalarial drug resistance. Particularly, artemether-lume…
The use of innovative approaches to strengthen health system resilience during the Covid-19 pandemic
This article is part of the Research Topic ‘ Health Systems Recovery in the Context of COVID-19 and Protracted Conflict ’. The COVID-19 pandemic has exposed the vulnerabilities and limitations of many health systems and underscored the need for strengthening health system resilience to make and sustain progress toward Universal Health Coverage (UHC), global health security and healthier populations in tandem. In response to the COVID-19 pandemic,…
No prominent works on this page.
The use of innovative approaches to strengthen health system resilience during the Covid-19 pandemic
This article is part of the Research Topic ‘ Health Systems Recovery in the Context of COVID-19 and Protracted Conflict ’. The COVID-19 pandemic has exposed the vulnerabilities and limitations of many health systems and underscored the need for strengthening health system resilience to make and sustain progress toward Universal Health Coverage (UHC), global health security and healthier populations in tandem. In response to the COVID-19 pandemic,…
Three decades of community health workers in primary healthcare delivery in Rwanda
BACKGROUND: Community health workers (CHWs) have been instrumental in the delivery of primary healthcare (PHC) services in Rwanda since 1995, with their responsibilities expanding from basic health promotion to integrated community case management. This study explored the evolution, contributions, challenges and policy implications of Rwanda CHW programme over the past three decades. METHODS: A qualitative descriptive study was conducted across 1…
Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda
Malaria treatment failures associated with reduced efficacy of chloroquine (CQ) and amodiaquine (AQ) antimalarial drugs emerged in Rwanda during the 1980s, prompting the policy shift towards adopting artemisinin-based combination therapies in 2006 as an alternative. However, recent findings from malaria surveillance and therapeutic efficacy studies have revealed a countrywide increase in antimalarial drug resistance. Particularly, artemether-lume…
Institutionalizing medical certification of cause of death training
Health care (2 works) · Amodiaquine (1 works) · Business (1 works) · Chloroquine (1 works) · Combination therapy (1 works) · Commonwealth (1 works) · Community health (1 works) · Community health workers (1 works) · Computational Drug Discovery Methods (1 works) · COVID-19 epidemiological studies (1 works)